Drug and alcohol review最新文献

{"title":"Etomidate-Adulterated Vaping: Fragmented Global Drug Control and Public Health Risks","authors":"Nicholas Lassi,&nbsp;Su Jiang","doi":"10.1111/dar.70188","DOIUrl":"10.1111/dar.70188","url":null,"abstract":"<div>\u0000 \u0000 \u0000 <section>\u0000 \u0000 <h3> Issue</h3>\u0000 \u0000 <p>This study examines the spread of etomidate-adulterated vaping products (‘k-pods’, ‘space oil’ or ‘zombie cigarettes’) and compares legal and policy responses across affected jurisdictions.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Approach</h3>\u0000 \u0000 <p>Through a review of government reports, forensic data and statutory instruments, the analysis reconstructs the geographic spread of etomidate and its analogues, evaluates their toxicological hazards when aerosolised, and contrasts divergent regulatory strategies.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Key Findings</h3>\u0000 \u0000 <p>Findings show that detection and enforcement are concentrated in East and Southeast Asia, where jurisdictions vary between criminal-control and pharmaceutical-control models. The study recommends three interlocking reforms: (i) adoption of broad-spectrum analogue legislation; (ii) investment in regional forensic infrastructure; and (iii) enhanced real-time information-sharing platforms. These measures would close regulatory loopholes, strengthen surveillance and prosecution, preserve legitimate clinical access, and reduce illicit manufacture, distribution and online commercialisation of etomidate-contaminated vaping products.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Conclusions</h3>\u0000 \u0000 <p>Etomidate-adulterated vaping constitutes an international governance and public health challenge that is best countered through synchronised legal reform, enhanced forensic infrastructure and accelerated cross-jurisdictional intelligence sharing.</p>\u0000 </section>\u0000 </div>","PeriodicalId":11318,"journal":{"name":"Drug and alcohol review","volume":"45 5","pages":""},"PeriodicalIF":2.6,"publicationDate":"2026-06-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148224151","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Alcohol in the Workplace: A Qualitative Study of Employees' Experiences With Employer-Supported Alcohol Treatment","authors":"Isabella Pistone,&nbsp;Martina Martinez,&nbsp;Morten Sager,&nbsp;Kristina Berglund","doi":"10.1111/dar.70194","DOIUrl":"10.1111/dar.70194","url":null,"abstract":"<div>\u0000 \u0000 \u0000 <section>\u0000 \u0000 <h3> Introduction</h3>\u0000 \u0000 <p>Alcohol use disorder is a major public health issue, impacting health, well-being, relationships and work performance. In Sweden, employers are legally required to provide access to and cover the cost of alcohol treatment for individuals with alcohol use disorder. Employer-supported alcohol treatment is therefore rather common in Sweden; however, research on employees' experiences with this type of treatment remains unexplored. This qualitative study investigates how a group of Swedish employees who had received employer-supported alcohol treatment experienced workplace management before, during and after treatment.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Method</h3>\u0000 \u0000 <p>Interviews with 15 participants were analysed using thematic analysis, revealing three key themes.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Results</h3>\u0000 \u0000 <p>The first theme highlights that many participants viewed their employer as a lifeline, experiencing relief when they received support to seek help for their alcohol problems. The second theme captures employees' reliance on their employer's ability to handle the situation, emphasising the crucial role managers play in the process, with varying levels of competence and support. Third, participants often felt alone upon returning to work, facing a discrepancy between their expectations of support and the actual workplace support provided post-treatment.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Discussion and Conclusions</h3>\u0000 \u0000 <p>The findings show how employer-supported treatment may facilitate access to care and workplace reintegration under relatively favourable circumstances, particularly when supported by managerial competence, clear routines and continued follow-up.</p>\u0000 </section>\u0000 </div>","PeriodicalId":11318,"journal":{"name":"Drug and alcohol review","volume":"45 5","pages":""},"PeriodicalIF":2.6,"publicationDate":"2026-06-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1111/dar.70194","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148224091","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Prevalence and Correlates of Reporting a Gabapentin Prescription for Pain Among People Who Use Opioids: A Longitudinal Community-Recruited Study","authors":"Evelyne Marie Piret,&nbsp;Heather Palis,&nbsp;Alexis Crabtree,&nbsp;JinCheol Choi,&nbsp;Kora DeBeck,&nbsp;Kanna Hayashi,&nbsp;Michael R. Law,&nbsp;M.-J. Milloy","doi":"10.1111/dar.70186","DOIUrl":"10.1111/dar.70186","url":null,"abstract":"<div>\u0000 \u0000 \u0000 <section>\u0000 \u0000 <h3> Introduction</h3>\u0000 \u0000 <p>Gabapentin is widely prescribed off-label to treat pain. However, there are concerns about the proliferation of medical and non-medical use, and the potential increased risk of overdose death associated with concurrent opioid use. Despite these considerations, prescription gabapentin use among people who use unregulated drugs is uncharacterised in Canada. Therefore, we investigated trends and factors associated with being prescribed gabapentin for pain among community-recruited people who use opioids.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Methods</h3>\u0000 \u0000 <p>Data were derived from three prospective cohort studies of people who use unregulated drugs in Vancouver, Canada, restricted to periods of opioid use (i.e., unregulated use, non-medical use, and/or opioid agonist treatment). We characterised factors associated with reporting gabapentin for pain between 2014 and 2020 using multivariable generalised estimating equations. Trends in self-reported prescription (2014–2020) and non-medical (2016–2024) gabapentin use were explored.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Results</h3>\u0000 \u0000 <p>Between 2014 and 2020, we included 10,999 observations from 2039 participants who had a baseline median age of 38 years and were 62.4% male and 57.5% White. Gabapentin prescriptions for pain were reported by 255 (12.5%) participants. Observations reporting a neuropathic pain diagnosis had 3.54 times the adjusted odds (95% CI 2.81, 4.46) of being prescribed gabapentin. From 2014 to 2020, the prevalence of gabapentin prescriptions rose from 5.4% to 7.8%. Non-medical gabapentin use remained low.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Discussion and Conclusions</h3>\u0000 \u0000 <p>Among people who use opioids, we observed an increase in gabapentin prescriptions for pain between 2014 and 2020. Gabapentin prescriptions were strongly associated with reporting a neuropathic pain diagnosis. Rates of non-medical gabapentin use were substantially lower than rates reported internationally.</p>\u0000 </section>\u0000 </div>","PeriodicalId":11318,"journal":{"name":"Drug and alcohol review","volume":"45 5","pages":""},"PeriodicalIF":2.6,"publicationDate":"2026-06-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1111/dar.70186","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148216849","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Personalised Perception: The Effect of Personality on the Sensory Effects of Psychedelics","authors":"Alexander Boardman,&nbsp;Jai Whelan,&nbsp;Ryan D. Ward","doi":"10.1111/dar.70172","DOIUrl":"10.1111/dar.70172","url":null,"abstract":"<div>\u0000 \u0000 \u0000 <section>\u0000 \u0000 <h3> Introduction</h3>\u0000 \u0000 <p>Psychedelics induce a wide range of sensory distortions and hallucinations (henceforth ‘distortions’). Yet, little is known about factors that influence the occurrence of certain distortions. Extra-pharmacological variables including personality traits have been found to correlate with the occurrence of different subjective features during the acute psychedelic state. The current study aimed to examine the correlations between personality scores and the intensity of different distortions.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Methods</h3>\u0000 \u0000 <p>Four hundred and twenty-six psychedelic users recruited from Aotearoa New Zealand completed an online survey which examined the intensity of 20 different distortions and measured six different personality traits using the five-factor IPIP-NEO-60 and the 34-item Tellegen Absorption Scale.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Results</h3>\u0000 \u0000 <p>Spearman's correlation analysis and linear regression analysis revealed that the intensity of sensory distortions (including visual trails, objects ‘breathing’, field-of-vision changes, visual acuity changes, taste hallucinations, out-of-body experiences, experiences of other dimensions, and synaesthesia) was significantly correlated (<i>p</i> &lt; 0.05) and associated with personality trait scores, even when setting, dose, and demographic variables were controlled, although the strength of the association was moderate at best.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Discussion and Conclusions</h3>\u0000 \u0000 <p>These findings emphasise the role of personality as a key extra-pharmacological variable associated with the intensity of certain subjective features of the acute psychedelic state. These findings suggest that personality testing may be a valuable tool for the prediction of acute reactions to psychedelics. This information could be useful to clinicians and therapists in determining effective psychedelic-treatment approaches.</p>\u0000 </section>\u0000 </div>","PeriodicalId":11318,"journal":{"name":"Drug and alcohol review","volume":"45 5","pages":""},"PeriodicalIF":2.6,"publicationDate":"2026-06-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1111/dar.70172","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148216869","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Intranasal Mucosal Atomiser Devices: A Novel Harm Reduction Intervention","authors":"Hayden Green,&nbsp;Thileepan Naren,&nbsp;Brittany Chapman,&nbsp;Martyn Lloyd-Jones,&nbsp;Sione Crawford,&nbsp;Dean Membrey","doi":"10.1111/dar.70191","DOIUrl":"10.1111/dar.70191","url":null,"abstract":"<div>\u0000 \u0000 \u0000 <section>\u0000 \u0000 <h3> Introduction</h3>\u0000 \u0000 <p>Factors associated with diminished peripheral vein access, including age, prolonged history of injecting drug use and coadministration with other substances, are all increasing among people who inject drugs in Australia. This exposes individuals to increased risk of injecting related complications, including skin and soft tissue infection, neurovascular injury and deep vein thrombosis.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Case Presentation</h3>\u0000 \u0000 <p>Case 1 is a 48-year-old man with a 30-year history of injecting drug use who presents with recurrent skin and soft tissue infections requiring hospitalisation, surgery and extensive wound care. Case 2 is a 40-year-old woman who has been injecting heroin since her teens, predominantly into the femoral vein. She has developed significant chronic venous insufficiency and severe venous ulcers. Both consumers were motivated to reduce their injecting-related harms and were offered the use of an intranasal atomiser for heroin administration and reported both a positive use experience and an intention to continue to utilise the device.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Discussion and Conclusions</h3>\u0000 \u0000 <p>Intranasal administration of heroin via atomising device may be an effective harm reduction intervention. The efficacy of these devices is supported by evaluation within heroin-assisted treatment programs, where they are associated with high rates of treatment retention, a favourable user experience and 50% fewer injection episodes. Harm reduction benefits of these devices require further evaluation but are likely to include reduced rates of infection and overdose. Given the potential benefits, as supported by the two cases reported here, intranasal atomisers should be further evaluated for inclusion within community harm reduction programs.</p>\u0000 </section>\u0000 </div>","PeriodicalId":11318,"journal":{"name":"Drug and alcohol review","volume":"45 5","pages":""},"PeriodicalIF":2.6,"publicationDate":"2026-06-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1111/dar.70191","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148210492","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Prevalence of Unrecorded Alcohol Consumption and Associated Factors: Findings From a Nationally Representative Survey in Thailand in 2022","authors":"Sukhontha Siri,&nbsp;Nanapas Bhagaman,&nbsp;Sawitri Assanangkornchai,&nbsp;Jiraluck Nontarak","doi":"10.1111/dar.70173","DOIUrl":"10.1111/dar.70173","url":null,"abstract":"<div>\u0000 \u0000 \u0000 <section>\u0000 \u0000 <h3> Introduction</h3>\u0000 \u0000 <p>Evidence from the World Health Organization shows that measures exist to regulate both recorded and unrecorded alcohol. In Thailand, comprehensive evidence on the amount of unrecorded alcohol consumed is lacking. This study aims to quantify the prevalence of unrecorded alcohol consumption and determine associated factors.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Methods</h3>\u0000 \u0000 <p>A cross-sectional survey was conducted from July to August 2022. Thai residents aged 15 years or above were recruited from 15 provinces, including Bangkok, using stratified multi-stage sampling. Types of unrecorded alcohol included surrogate, home-brewed, smuggled or industrially produced illegal and duty-free outlet products. Annual alcohol consumption was calculated by multiplying the daily quantity by the estimated number of drinking days.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Results</h3>\u0000 \u0000 <p>Among 3924 participants, unrecorded alcohol constituted 4.4% (95% CI 4.3–4.4) of the total alcohol consumption (10.9 million of 248.5 million litres/year). The annual unrecorded pure alcohol intake per current drinker was 2.2 L. Drinkers aged 45–59 years had the highest prevalence of unrecorded alcohol consumption (13.2%), while those aged 60 years and over had the largest share (10.0%). Consumption was higher in males (2.5 L/year) compared to females (0.5 L/year) and heavy episodic drinking individuals (3.2 L/year) compared to non-heavy episodic drinking individuals (0.9 L/year).</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Discussion and Conclusions</h3>\u0000 \u0000 <p>Although middle-aged adults had the highest consumption rates, the greatest intensity of intake and, therefore, potential for harm, was seen among older-aged and heavy episodic drinking individuals. Given the risks of unknown ethanol concentrations and contaminants in unrecorded products, policymakers should prioritise high-intensity users over overall prevalence to better mitigate risks within Thailand's alcohol consumption profile.</p>\u0000 </section>\u0000 </div>","PeriodicalId":11318,"journal":{"name":"Drug and alcohol review","volume":"45 5","pages":""},"PeriodicalIF":2.6,"publicationDate":"2026-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1111/dar.70173","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148142988","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Adapting ‘The Grog App’ to Ask Aboriginal and Torres Strait Islander Peoples About Their Drinking in Primary Healthcare: A Delphi Study","authors":"Mustafa Al Ansari,&nbsp;Angela Dawson,&nbsp;Monika Dzidowska,&nbsp;James H. Conigrave,&nbsp;Annalee Stearne,&nbsp;Katherine M. Conigrave,&nbsp;Marguerite Tracy,&nbsp;Scott Wilson,&nbsp;Noel Hayman,&nbsp;Dan Wilson,&nbsp;Lynette Bullen,&nbsp;Jimmy Perry,&nbsp;Taleah Reynolds,&nbsp;Jocelyn Dhu,&nbsp;K. S. Kylie Lee","doi":"10.1111/dar.70171","DOIUrl":"10.1111/dar.70171","url":null,"abstract":"<div>\u0000 \u0000 \u0000 <section>\u0000 \u0000 <h3> Introduction</h3>\u0000 \u0000 <p>Alcohol screening in primary healthcare services, including Aboriginal Community Controlled Health Organisations, may encounter barriers. These include time constraints, competing health priorities and sensitivities about the topic. Digital tools like the Grog App, validated in population settings, offer potential opportunities to overcome these barriers.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Methods</h3>\u0000 \u0000 <p>We conducted a three-round Delphi study to gain consensus on items to include in a digital alcohol screening tool for Aboriginal and Torres Strait Islander people accessing primary healthcare services (‘Grog Check’). Twelve Australian health experts, of whom a majority were Aboriginal or Torres Strait Islanders (67%, <i>n</i> = 8/12), evaluated the clinical importance of potential items (consensus level: 80%). Panellists had expertise in drug and alcohol, primary care, addiction medicine and Indigenous health.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Results</h3>\u0000 \u0000 <p>Half of the 42 questions, relating to 24 items, reached consensus. Panellists agreed that the screening tool should be brief and culturally relevant. Of the 24 items, there was consensus on 17 including pregnancy, episodic drinking, harms and dependence. Panellists agreed on asking individuals about worries from their own drinking but were divided on asking about worries from others' drinking. There was consensus to ask about dependence, but no agreement if everyone should be asked or only high-risk individuals. Panellists endorsed including a ‘cheat-sheet’ to guide clinicians on interpretating results and next steps.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Discussion and Conclusions</h3>\u0000 \u0000 <p>We identified questions for a digital alcohol screening tool (Grog Check). This app has the potential to support clinicians and enable safer ways for Aboriginal and Torres Strait Islander people to describe their drinking in primary healthcare settings.</p>\u0000 </section>\u0000 </div>","PeriodicalId":11318,"journal":{"name":"Drug and alcohol review","volume":"45 5","pages":""},"PeriodicalIF":2.6,"publicationDate":"2026-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1111/dar.70171","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148142985","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Experiences of a Pre-Treatment Sober Month in Individuals With Alcohol Use Disorder Pursuing Controlled Drinking Goals","authors":"Stina Ingesson-Hammarberg,&nbsp;Sara Wallhed Finn,&nbsp;Anders Hammarberg,&nbsp;Magnus Johansson,&nbsp;Sven Andréasson,&nbsp;Christina Nehlin","doi":"10.1111/dar.70179","DOIUrl":"10.1111/dar.70179","url":null,"abstract":"<div>\u0000 \u0000 \u0000 <section>\u0000 \u0000 <h3> Introduction</h3>\u0000 \u0000 <p>Interest in managing alcohol-related risks through temporary abstinence challenges has grown significantly. Studies on abstinence challenges in the general population show improvements in for example mental health, blood pressure, insulin resistance and alcohol consumption, but studies in clinical samples are lacking, including qualitative research on patients' perspectives on such a clinical intervention. This study aimed to explore the patients' experiences of a sober month before initiating psychological treatment for controlled drinking.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Methods</h3>\u0000 \u0000 <p>A qualitative interview study (<i>n</i> = 14) was conducted at a specialised addiction clinic in Stockholm, Sweden. Participants were recruited within a randomised controlled trial examining a sober month as an adjunct to psychological treatment for controlled drinking. Data were analysed with applied thematic analysis.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Results</h3>\u0000 \u0000 <p>Four themes were identified: (i) Breaking the cycle of habitual drinking; (ii) Regaining control; (iii) A sober month made abstinence a more prominent part of goals; and (iv) A failed attempt at sobriety as a setback to change. A sober month was perceived as positive for most patients and became a challenge that increased the sense of control and perceived ability to abstain. The benefits of the sober month made participants consider more restrictive goals or abstinence over time. Not being able to abstain made participants less motivated and reconsidered controlled drinking as their goal.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Discussion and Conclusions</h3>\u0000 \u0000 <p>Having a sober month can increase awareness of the ability to abstain and guide patients toward lower consumption goals. To reduce the risks of negative consequences, it is important to identify and support those who do not manage to abstain.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Trial Registration</h3>\u0000 \u0000 <p>ClinicalTrials.gov identifier: 47033189</p>\u0000 </section>\u0000 </div>","PeriodicalId":11318,"journal":{"name":"Drug and alcohol review","volume":"45 5","pages":""},"PeriodicalIF":2.6,"publicationDate":"2026-05-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1111/dar.70179","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148137018","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Alcohol Use and Women's Nutritional Status in India: Evidence From a Peer-Based Instrumental Variable Approach","authors":"Deepak Kumar,&nbsp;Manzoor Malik","doi":"10.1111/dar.70180","DOIUrl":"10.1111/dar.70180","url":null,"abstract":"<div>\u0000 \u0000 \u0000 <section>\u0000 \u0000 <h3> Introduction</h3>\u0000 \u0000 <p>This paper estimates the effect of women's alcohol use on body mass index (BMI) and related indicators of nutritional outcomes in India.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Methods</h3>\u0000 \u0000 <p>Using nationally representative data from the fifth round of the National Family Health Survey, we employ an instrumental variables strategy that leverages peer drinking prevalence within district–age clusters to address the endogeneity of alcohol use. The instrument captures local exposure to social drinking norms while mitigating reflection bias through a leave-one-out construction.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Results</h3>\u0000 \u0000 <p>The results show a robust and significant negative relationship between drinking and women's nutritional outcomes. After correcting for endogeneity, alcohol use is associated with lower BMI and a reduced likelihood of being overweight. These effects are consistent across caste groups, residence types and policy environments, with stronger impacts observed among women from rural or socioeconomically disadvantaged backgrounds.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Discussion and Conclusions</h3>\u0000 \u0000 <p>The findings suggest that household resource constraints and the social stigma surrounding women's drinking jointly contribute to these outcomes. By providing evidence on the nutritional effects of alcohol use, this study highlights an overlooked dimension of women's health in developing contexts. The analysis also extends peer-based identification strategies to the study of nutrition and health behaviour, offering new insights into how social norms shape gendered health disparities.</p>\u0000 </section>\u0000 </div>","PeriodicalId":11318,"journal":{"name":"Drug and alcohol review","volume":"45 5","pages":""},"PeriodicalIF":2.6,"publicationDate":"2026-05-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148137074","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Correction to “Exploring Age and Sex Differences in the Use of Cannabis Vaping Products: Results From the Canadian Cannabis Survey 2020–2023”","authors":"","doi":"10.1111/dar.70184","DOIUrl":"10.1111/dar.70184","url":null,"abstract":"<p>\u0000 <span>F. Fataar</span>, <span>M. J. Dann</span>, <span>S. Goodman</span>, and <span>H. Abramovici</span>, “ <span>Exploring Age and Sex Differences in the Use of Cannabis Vaping Products: Results From the Canadian Cannabis Survey 2020–2023</span>,” <i>Drug and Alcohol Review</i> <span>45</span>, no. <span>4</span> (<span>2026</span>): e70155, https://doi.org/10.1111/dar.70155.\u0000 </p><p>In Table 3, the header of the third column, ‘6–19 vs. 25+ (ref)’ was incorrect. This should have read: ‘16–19 vs. 25+ (ref)’.</p><p>We apologise for this error.</p>","PeriodicalId":11318,"journal":{"name":"Drug and alcohol review","volume":"45 5","pages":""},"PeriodicalIF":2.6,"publicationDate":"2026-05-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1111/dar.70184","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148053420","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}